VP, Finance @ Ocera Therapeutics (June 2014 - December 2014)
Corporate Controller @ (March 2010 - December 2014)
Director, Finance @ NeurogesX, Inc. (June 2007 - March 2010)
Manager, Finance and Accounting @ Lipid Sciences (January 2002 - January 2007)
Financial Analyst @ ADAC Laboratories, A Philips Medical Systems Company (January 2000 - January 2002)
GL Accountant @ Bay View Capital (January 1997 - January 2000)
Michael Byrnes Education
California State University - East Bay
MBA (Finance)
2003-2005
Santa Clara University
BSC (Finance)
1998-2000
Michael Byrnes Skills
Strategic Planning
Financial Planning
Financial Modeling
SEC Reporting
Technical Accounting
Revenue Recognition
Financial Reporting
Accounting
Sarbanes-Oxley
Biotechnology
Due Diligence
Financial Analysis
Treasury
SEC filings
Sarbanes-Oxley Act
Forecasting
Account Reconciliation
General Ledger
Finance
Mergers & Acquisitions
Strategic Financial Planning
Strategy
Internal Controls
IPO
Lifesciences
Life Sciences
U.S. SEC Filings
Sales
Sarbanes Oxley
Marketing
Sarbanes Oxley Act
Strategic Financial
Mergers and Acquisitions
Analysis
Microsoft Excel
Budgets
Michael Byrnes Summary
Michael Byrnes, based in California, United States, is currently a Chief Financial Officer at Fore Biotherapeutics. Michael Byrnes brings experience from previous roles at CERo Therapeutics, Inc., eFFECTOR Therapeutics, Inc., Principia Biopharma and Alkahest, Inc.. Michael Byrnes holds a 2003 - 2005 MBA in Finance @ California State University - East Bay. With a robust skill set that includes Strategic Planning, Financial Planning, Financial Modeling, SEC Reporting, Technical Accounting and more. Michael Byrnes has 5 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Byrnes?
Find contact details for 700 million professionals.